Mp10-07 Increased Risk of Bladder Cancer in Chronic Kidney Disease Patients With Renal Transplantation

Abstract

This large cohort represents a unique opportunity to asses for differences in what is otherwise a rare condition and to our knowledge is the first to suggest that DnUTUC may represent a distinct clinical entity from BC. Although surveillance bias may explain the baseline differences in tumor characteristics, multivariate adjustment still demonstrates a distinct outcome for these patients. Further investigations including biomarker profiling between DnUTUC and SUTUC may further shed light into biological differences between these heretofore similar microscopic entities.